Spinocerebellar Ataxia Type 11
Symptoms, Doctors, Treatments, Advances & More

Spinocerebellar Ataxia Type 11 Overview

Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 11

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia Type 11?
Spinocerebellar ataxia type 11 (SCA11) is characterized by progressive cerebellar ataxia (difficulty walking and balance) and abnormal eye signs (jerky pursuit, horizontal and vertical movements (nystagmus), pyramidal features (increased muscular tonus, increased reflexes and an abnormal reflex known as Babinski sign and inability to make to perform fine movements), peripheral neuropathy with numbness, weakness or pain in the feet or hands or other places of the body and dystonia. Diagnosis is based on signs and symptoms and is confirmed by genetic testing finding a change in the TTBK2 gene. It is inherited in an autosomal dominant manner.
What are the alternative names for Spinocerebellar Ataxia Type 11?
  • Spinocerebellar ataxia 11
  • SCA11
  • Spinocerebellar ataxia type 11
Who are the top Spinocerebellar Ataxia Type 11 Local Doctors?
Advanced in Spinocerebellar Ataxia Type 11
Dr. Amy E. Brown
Neurology
Advanced in Spinocerebellar Ataxia Type 11
Dr. Amy E. Brown
Neurology

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
615-936-0060
Languages Spoken:
English
See accepted insurances
Offers Telehealth

. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, and Hereditary Ataxia. Dr. Brown is board certified in  .

Experienced in Spinocerebellar Ataxia Type 11
Dr. Taylor A. Finseth
Neurology
Experienced in Spinocerebellar Ataxia Type 11
Dr. Taylor A. Finseth
Neurology

Aurora Neuroscience Innovation

2801 W Kinnickinnic River Pkwy, Ste 550, 
Milwaukee, WI 
414-385-8780
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Taylor Finseth is a Neurologist practicing medicine in Milwaukee, Wisconsin. Dr. Finseth is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Camptocormism, Parkinson's Disease, Movement Disorders, and Conversion Disorder. Dr. Finseth is board certified in American Board Of Psychiatry & Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Spinocerebellar Ataxia Type 11
Dr. Kathryn Gaines
Neurology
Experienced in Spinocerebellar Ataxia Type 11
Dr. Kathryn Gaines
Neurology

Aurora Neurology

3003 W Good Hope Rd, 
Milwaukee, WI 
414-352-3100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kathryn Gaines is a Neurologist practicing medicine in Milwaukee, Wisconsin. Dr. Gaines is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, and Meige Syndrome. Dr. Gaines is board certified in American Board Of Psychiatry & Neurology.

View All Doctors
What are the latest Spinocerebellar Ataxia Type 11 Clinical Trials?
Coordination of Rare Diseases at Sanford
Coordination of Rare Diseases at Sanford
Enrollment Status: Recruiting
Publish Date: May 29, 2025

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center